Seth Bergey

Emma cautioned AI margin impact will take years, starting with back-office functions (HR, shared services) before reaching operating segments. Declined to speculate on magnitude.

Emma confirmed unchanged capital allocation priorities with even greater M&A opportunity in data centers. AI investment remains organic through CapEx, not through acquiring AI companies. Buybacks fill remainder when share price is undervalued.

Emma confirmed guidance range ($7.30-$7.60) almost entirely driven by data center land site monetization timing, specifically uncertainty around securing power to sites.

Bob confirmed actively adding brokers with Americas brokerage leadership team assembled in Dallas this week. AI savings come from research costs and data delivery efficiency, not headcount reductions.

Bob acknowledged power as the primary constraint for data center land. CBRE's strategy is acquiring and entitling land to position hyperscalers to work with utility authorities for power access.

Bob noted Q3 saw a resurgence of gateway markets (New York, San Francisco) after Q2's secondary market strength. Emphasized real estate has become much more strategic to companies for culture and productivity, supporting sustained broad-based demand.

Bob confirmed no hiring plan changes beyond normal growth needs, noting technology is enabling more efficiency per headcount over time.

Bob noted clients would like rate cuts but aren't waiting for them; expectations more positive than 90 days ago though some European choppiness remains.

Emma gave high-level breakdown: office metrics broadly positive across all dimensions; industrial seeing slight increases in footage and term with flat rent.

Scott Bohn said conversion from tour to execution runs 3 to 9 months depending on the deal and has been relatively consistent over the past 12 months.

Bergey asked how Gateway is tracking vs underwriting and whether lease economics are changing. Brinker said ahead of schedule with rents at or above underwriting; upside should materialize in 2027-2028 earnings.

Brinker declined to specify allocation, emphasizing balance sheet protection as #1 priority with flexibility across all three deployment options.

Brinker specified double-digit unlevered IRRs for lab distress, 7%+ for outpatient development, with implied stock price also considered as alternative deployment.

Management emphasized flexibility and optionality in capital deployment depending on stock price and investment opportunities.

Bohn confirmed most LOIs are in operating portfolio rather than development. Not ready to share deal details until execution.

Owen said pricing hasn't changed much. More capital returning to office with Q1 sales up 72% YoY. Remaining 2026 dispositions will shift toward nonstrategic office and land as residential sales are largely complete.

Doug said portfolio-wide cash mark-to-market on occupied space is high 4% to low 5%, a meaningful jump from a year ago. Back Bay Boston and Manhattan tops of buildings seeing biggest improvements. D.C. structurally rolls down due to high annual escalations. West Coast base rents stable but not improving. Occupancy gain is far more impactful than mark-to-market in 2026-2027.

Mike said timing of sales is the key variable. More assets under contract and in market than at Investor Day with good buyer demand. Acknowledged could be slightly more dilutive if sales close significantly earlier, but hard to provide better range until next quarter or two.

Mike detailed Reston Corporate Center removed for 3M sq ft next-phase development, Reservoir Place (350K sq ft) removed for redevelopment. Development deliveries adding 50-70bp vacancy drag, offset by 250-300K sq ft of suburban removals.

Hutchens confirmed cap rate compression across the market while holding Ventas underwriting yields steady in the mid-6s.

Probst walked the guidance bridge item by item and confirmed the implied back-half run rate rather than deflecting.

Hutchens pointed to July tracking at or above June's 60bps sequential growth but noted much of selling season still to play out.

Hutchens said both occupancy and rate are drivers; platform designed for both. As communities move into higher occupancy bands, RevPOR should play bigger role.

Mitra quantified the dispersion and reframed the business system as an efficacy rather than efficiency program.

Chaudhri described 90-95% off-market sourcing, 30-day close timeline vs 6-month industry average. Deals that got away to other buyers are returning after retrading. Mitra emphasized reputation as currency, no retrading, visiting every asset with 12-person teams including structural engineers.

Nikhil and Shankh emphasized fund business is opportunistic and tactical, not an asset-gathering mandate; debt fund originated from LP suggestion; Shankh criticized industry trend toward capital-raising over money-making.

Management declined to quantify pipeline but Nikhil explained broken deals from 6-10 month macro swings are driving first calls to Welltower.

Peter pointed to a significant increase in the 20,000-100,000 sq ft mid-barbell segment, typically public biotech, tied to IPOs and secondaries. Hallie added demand is broad across life science tools while public biotech still lags.

Joel said the change was out of an abundance of caution until public biotech returns. Marc noted the 1.4M sq ft of known vacates won't be retained and downtime reflects both lease-up and capital deployment; 60-70% retention modeled on other 2026 expirations.